REVISÃO SISTEMÁTICA
暂无分享,去创建一个
Maria Rosa Chitolina | B. C. M. S. Maculan | E. Aganette | Marcos Antonio Ferreira Júnior | Oleci Pereira Frota | Priscila Fernandes Meireles Câmara | Maykson Cardoso | Renato Varella Bueno | Viviane Euzébia Perreira Santos | Marcos Antonio Borges Junior | Allyne Fortes Vitor | Maria Catarina Chitolina Zanini | Lucas Santiago dos Santos
[1] Yaiza Beatriz Molero-Díez,et al. Fourth universal definition of myocardial infarction , 2019, Colombian Journal of Anesthesiology.
[2] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[3] C. Johnson,et al. Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control. , 2018, Global heart.
[4] Deepak L. Bhatt,et al. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. , 2017, Circulation. Cardiovascular quality and outcomes.
[5] Antonio de Padua Mansur,et al. V Diretriz da Sociedade Brasileira de Cardiologia sobre Tratamento do Infarto Agudo do Miocárdio com Supradesnível do Segmento ST , 2015 .
[6] R. Henning,et al. Recent advances in the diagnosis and treatment of acute myocardial infarction. , 2015, World journal of cardiology.
[7] C. A. Gottschall,et al. Prevalência, etiologia e características dos pacientes com infarto agudo do miocárdio tipo 2 , 2015 .
[8] Md. Ramjan Ali,et al. Aspect of Thrombolytic Therapy: A Review , 2014, TheScientificWorldJournal.
[9] P. Sahoo,et al. Role of thrombolysis in reperfusion therapy for management of AMI: Indian scenario. , 2013, Indian heart journal.
[10] P. Armstrong,et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. , 2013, New England Journal of Medicine.
[11] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[12] G. Levine,et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. , 2011, Circulation.
[13] P. Armstrong,et al. Reperfusion Paradox in ST-Segment Elevation Myocardial Infarction , 2011, Annals of Internal Medicine.
[14] M. Moeini,et al. Reviewing time intervals from onset of the symptoms to thrombolytic therapy in patients with ST segment elevation myocardial infarction (STEMI) , 2010, Iranian journal of nursing and midwifery research.
[15] M. Shuster,et al. Part 9: Acute Coronary Syndromes: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.
[16] P. Armstrong,et al. The Strategic Reperfusion Early After Myocardial Infarction (STREAM) study. , 2010, American heart journal.
[17] S. Halvorsen,et al. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). , 2010, Journal of the American College of Cardiology.
[18] L. Morrison,et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. , 2009, The New England journal of medicine.
[19] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.
[20] A. Mullasari. Strategy of in ambulance thrombolysis followed by routine PCI in acute myocardial infarction. , 2009, Indian Heart Journal.
[21] P. Touboul,et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. , 2009, European heart journal.
[22] M. Flather,et al. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial , 2008, The Lancet.
[23] David P Miller,et al. Hospital Delays in Reperfusion for ST-Elevation Myocardial Infarction: Implications When Selecting a Reperfusion Strategy , 2006, Circulation.
[24] P. Touboul,et al. Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial. , 2005, European heart journal.
[25] P. Touboul,et al. Impact of Time to Treatment on Mortality After Prehospital Fibrinolysis or Primary Angioplasty: Data From the CAPTIM Randomized Clinical Trial , 2003, Circulation.
[26] C. Bode,et al. Case 2: Patent foramen ovale (PFO) and paradoxical embolism , 2003, Heart.
[27] A. Favero,et al. Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics , 2003, British medical journal.
[28] J. Rawles. GREAT: 10 year survival of patients with suspected acute myocardial infarction in a randomised comparison of prehospital and hospital thrombolysis , 2003, Heart.
[29] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction : a quantitative review of 23 randomised trials , 2022 .
[30] P. Touboul,et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study , 2002, The Lancet.
[31] E. Antman,et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. , 2002, Journal of the American College of Cardiology.
[32] L. Morrison,et al. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. , 2000, JAMA.
[33] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.